drugset / Trial / NCT03102762

Botulinum Toxin for Erectile Dysfunction

NCT03102762

Phase 2/3 Completed 70 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety and efficacy of intra-cavernosal Botulinum toxin injection as an alternative line of treatment in patients with erectile dysfunction - not responding to oral PDE5i - through cavernosal smooth muscle relaxation.

Timeline

Start
2017-01-03
Primary completion
2019-01-10
Completion
2019-01-10

Publications

  • Background Ghanem H, Soliman I, AbdulHamid M, et. PS-08-016 Can intracavernosal botulinum toxin injection salvage vascular erectile dysfunction patients not responding to oral and intracavernous therapy? A pilot study. May 2016. Volume 13, Issue 5, Supplement 2, Page S116.

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Other